| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
|
Soo, Hon Liong
|
|
|
24 |
9 |
p. 1890-1898
|
artikel
|
| 2 |
Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges
|
Vitorino, Carla
|
|
|
24 |
9 |
p. 1911-1923
|
artikel
|
| 3 |
Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells
|
Fernandes, Clara
|
|
|
24 |
9 |
p. 1836-1844
|
artikel
|
| 4 |
Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?
|
Gonçalves, Elaine D.
|
|
|
24 |
9 |
p. 1845-1853
|
artikel
|
| 5 |
Can we use Nature’s Structure-Activity-Relationships to Make Better Drugs?
|
Kenakin, Terry
|
|
|
24 |
9 |
p. 1701-1703
|
artikel
|
| 6 |
Contents page 1
|
|
|
|
24 |
9 |
p. i
|
artikel
|
| 7 |
Contents page 2
|
|
|
|
24 |
9 |
p. ii
|
artikel
|
| 8 |
Correlates of time to approval and other clinical development periods
|
Breder, Christopher D.
|
|
|
24 |
9 |
p. 1871-1876
|
artikel
|
| 9 |
Corrigendum to ‘Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development’ Drug Discovery Today 23 (2018) 1733–1745
|
Andersson, Shalini
|
|
|
24 |
9 |
p. 1953
|
artikel
|
| 10 |
Data science tools and applications on the way to Pharma 4.0
|
Steinwandter, Valentin
|
|
|
24 |
9 |
p. 1795-1805
|
artikel
|
| 11 |
Endothelin-1 traps as a potential therapeutic tool: from diabetes to beyond?
|
Jain, Arjun
|
|
|
24 |
9 |
p. 1937-1942
|
artikel
|
| 12 |
Engineering microsystems to recapitulate brain physiology on a chip
|
Ndyabawe, Kenneth
|
|
|
24 |
9 |
p. 1725-1730
|
artikel
|
| 13 |
Future unmet medical need as a guiding principle for pharmaceutical R&D
|
Vennemann, Matthias
|
|
|
24 |
9 |
p. 1924-1929
|
artikel
|
| 14 |
Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application
|
Simões, Marta F.
|
|
|
24 |
9 |
p. 1749-1768
|
artikel
|
| 15 |
Impact of organ-on-a-chip technology on pharmaceutical R&D costs
|
Franzen, Nora
|
|
|
24 |
9 |
p. 1720-1724
|
artikel
|
| 16 |
Incorporating liquid biopsies into treatment decision-making: obstacles and possibilities
|
Beije, Nick
|
|
|
24 |
9 |
p. 1715-1719
|
artikel
|
| 17 |
2018 in review: FDA approvals of new molecular entities
|
Kinch, Michael S.
|
|
|
24 |
9 |
p. 1710-1714
|
artikel
|
| 18 |
Mini-gut: a promising model for drug development
|
Yin, Yue-Bang
|
|
|
24 |
9 |
p. 1784-1794
|
artikel
|
| 19 |
Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives
|
Deb, Pran Kishore
|
|
|
24 |
9 |
p. 1854-1864
|
artikel
|
| 20 |
Oxidative phosphorylation inducers fight pathological angiogenesis
|
Bayona-Bafaluy, M.Pilar
|
|
|
24 |
9 |
p. 1731-1734
|
artikel
|
| 21 |
Peptide-based protease inhibitors from plants
|
Hellinger, Roland
|
|
|
24 |
9 |
p. 1877-1889
|
artikel
|
| 22 |
Physicians in the pharmaceutical industry: their roles, motivations, and perspectives
|
Sweiti, Hussein
|
|
|
24 |
9 |
p. 1865-1870
|
artikel
|
| 23 |
Skin metabolism phase I and phase II enzymes in native and reconstructed human skin: a short review
|
Kazem, Siamaque
|
|
|
24 |
9 |
p. 1899-1910
|
artikel
|
| 24 |
Standpoint on the priority of TNTs and CNTs as targeted drug delivery systems
|
Ranjous, Yasmin
|
|
|
24 |
9 |
p. 1704-1709
|
artikel
|
| 25 |
The current status of pharmacotherapy for the treatment of Parkinson’s disease: transition from single-target to multitarget therapy
|
Cheong, Siew L.
|
|
|
24 |
9 |
p. 1769-1783
|
artikel
|
| 26 |
The human endogenous metabolome as a pharmacology baseline for drug discovery
|
Bofill, Andreu
|
|
|
24 |
9 |
p. 1806-1820
|
artikel
|
| 27 |
The role of molecular simulations in understanding the mechanisms of cell-penetrating peptides
|
Reid, Lauren M.
|
|
|
24 |
9 |
p. 1821-1835
|
artikel
|
| 28 |
Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment
|
Bailly, Christian
|
|
|
24 |
9 |
p. 1930-1936
|
artikel
|
| 29 |
Unbiased data analytic strategies to improve biomarker discovery in precision medicine
|
Khan, Saifur R.
|
|
|
24 |
9 |
p. 1735-1748
|
artikel
|
| 30 |
Using molecular-mimicry-inducing pathways of pathogens as novel drug targets
|
Garg, Anjali
|
|
|
24 |
9 |
p. 1943-1952
|
artikel
|
Tijdschrift beschrijving